Overview

Safety and Efficacy of CDB-2914 for Emergency Contraception

Status:
Completed
Trial end date:
2009-06-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of CDB-2914 for preventing pregnancy when taken 3 to 5 days after unprotected sexual intercourse.
Phase:
Phase 3
Details
Lead Sponsor:
HRA Pharma
Treatments:
Ulipristal acetate